An altered Lecam1/ICAM1 ratio on CD34+cells predicts leukemic progression in MDS patients.

被引:0
|
作者
Buccisano, F [1 ]
Venditti, A [1 ]
Tamburini, A [1 ]
Del Poeta, G [1 ]
Maurillo, L [1 ]
Abruzzese, E [1 ]
Scornajenghi, KA [1 ]
Amadori, S [1 ]
机构
[1] Univ Roma Tor Vergata, I-00173 Rome, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2597
引用
收藏
页码:620A / 620A
页数:1
相关论文
共 50 条
  • [41] High PD-L1/CD86 ratio on plasmacytoid DC correlates with elevated frequency of T regulatory cells in operationally tolerant liver transplant patients.
    Tokita, Daisuke
    Mazariegos, George V.
    Zahorchak, Alan F.
    Raimondi, Giorgio
    Abe, Masanori
    Thomson, Angus W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 278 - 278
  • [42] ApoB:ApoA1 Ratio Could Predict Atherosclerotic Risk in Juvenile-SLE Patients Associated with Altered Interferon Signalling in CD8+T-cells
    Robinson, George
    Waddington, Kirsty
    Coelewij, Leda
    Peng, Junjie
    Naja, Meena
    Wincup, Chris
    Radziszewska, Anna
    Peckham, Hannah
    Isenberg, David
    Ioannou, Yiannis
    Torra, Ines Pineda
    Ciurtin, Coziana
    Jury, Elizabeth
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [43] The ratio of PD1+CD8+T cells in stromal area of tumor tissue is associated with the effect of neoadjuvant chemotherapy in HER2 negative breast cancer patients.
    Gong, Chang
    Lin, Qun
    Cen, Yinghuan
    Fang, Xiaolin
    Shi, Yu
    Chen, Letian
    Luo, Qing
    Duan, Zhuxi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [44] Expression of Ahi-1, a newly discovered gene activated by insertional mutagenesis in mouse models of leukemia and lymphoma, is highly deregulated in human leukemic cells lncluding Lin-CD34+CD38- CML cells from patients in chronic phase.
    Jiang, XY
    Zhao, Y
    Chan, WY
    Vercauteren, S
    Pang, E
    Nicolini, F
    Eaves, A
    Eaves, C
    BLOOD, 2003, 102 (11) : 577A - 577A
  • [45] Plasma levels of FL and SDF-1 and expression of FLT-3 and CXCR4 on CD34+cells assessed pre and post hematopoietic stem cell mobilization in patients with hematologic malignancies and in healthy donors
    Cecyn, Karin Zattar
    Schimieguel, Dulce Marta
    Sugano Kimura, Eliza Yuriko
    Yamamoto, Mihoko
    Rodrigues de Oliveira, Jose Salvador
    TRANSFUSION AND APHERESIS SCIENCE, 2009, 40 (03) : 159 - 167
  • [46] Improved disease free-survival after transplantation of highly purified peripheral blood CD34+cells as compared to unmanipulated BM or PBSCT from HLA-identical sibling donors in patients with 1CP CML
    Elmaagacli, AH
    Peceny, R
    Steckel, N
    Trenschel, R
    Ottinger, H
    Grosse-Wilde, H
    Schaefer, UW
    Beelen, DW
    BONE MARROW TRANSPLANTATION, 2002, 29 : S33 - S33
  • [47] EXPRESSION OF H-OCT1 PREDICTS FOR ACHIEVEMENT OF CCYR IN IMATINIB TREATED PATIENTS WHILE THE LEVEL OF PHOSPHO-CRKL INHIBITION IN CD34 POSITIVE CELLS SEEMS TO BE OF LITTLE PROGNOSTIC VALUE
    Khorashad, S. Sorouri
    Wagner, S.
    Marin, D.
    Reid, A. G.
    Milojkovic, D.
    Willimott, S.
    Gerrard, G.
    Foroni, L.
    Goldman, J. M.
    Apperley, J. E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 50 - 50
  • [48] Outcome of transplantation of highly purified peripheral blood CD34+cells with T cell add-back compared to unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with 1st chronic phase CML
    Elmaagacli, AH
    Peceny, R
    Steckel, NC
    Trenschel, R
    Ottinger, H
    Beelen, DW
    BONE MARROW TRANSPLANTATION, 2003, 31 : S48 - S49
  • [49] RETRACTION: EBF1 gene promotes the proliferation and inhibits the apoptosis of bone marrow CD34+cells in patients with myelodysplastic syndrome through negative regulation of mitogen-activated protein kinase axis (Retraction of Vol 120, Pg 1407, 2019)
    Hou, Shuang
    Hao, Jie
    Wang, Yan-Yu
    Zhao, Bing-Bing
    Xiao, Gong-Wei
    Li, Yan-Qing
    Liu, Xi
    Zou, Zhi-Lan
    Yao, Ye
    Xiong, Hong
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2021, 122 : S113 - S113
  • [50] HIGH-YIELD OF CD34+CELLS WITH BORTEZOMIB-BASED MOBILIZATION REGIMEN IS ASSOCIATED WITH SPECIFIC GENOMIC EXPRESSION PATTERNS, DECREASE IN SDF-1 PLASMA LEVELS AND UP-REGULATION OF CXCR4 IN MULTIPLE MYELOMA (MM) PATIENTS
    Ward, M. M.
    Mark, T.
    Manco, M.
    Stern, J.
    O'Loughlin, J.
    Shore, T. B.
    Pearse, R. N.
    Jayabalan, D.
    Skerrett, D.
    Chen-King, S.
    Lane, M. E.
    Niesvizky, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S179 - S180